Home  |  My Account  |  View Cart  |  Checkout



A small molecule enhances RNA interference and promotes microRNA processing

September 2nd, 2008

Small interfering RNAs (siRNAs) and microRNAs (miRNAs) are sequence-specific post-transcriptional regulators of gene expression. Although major components of the RNA interference (RNAi) pathway have been identified, regulatory mechanisms for this pathway remain largely unknown. Here we demonstrate that the RNAi pathway can be modulated intracellularly by small molecules.

(PDF) Read Full Article

Effigene Pharmaceuticals receives NIH STTR Grant

August 29th, 2008

Company will investigate promising adjuvant that could open door for SiRNA-based Huntington’s Diseases treatments Read the rest of this entry »

Emory Team Uncovers Small Molecule that Boosts RNAi Silencing; Effigene to Sell Tech

July 24th, 2008

By Doug Macron

A research team led by investigators from Emory University this week published data showing how a novel cell-based assay technology, licensed to startup Effigene Pharmaceuticals, was able to identify a small molecule that could enhance siRNA-mediated mRNA degradation and endogenous microRNA biogenesis. Read the rest of this entry »

Class of antibiotics can enhance gene-silencing tool

July 20th, 2008

A way to turn off one gene at a time has earned acceptance in biology laboratories over the last decade. Doctors envision the technique, called RNA interference, as a tool to treat a variety of diseases if it can be adapted to humans

Read Full Article